HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].

Abstract
Three types of hybridomas were obtained by fusion of murine myeloma cells (NSI-1-Ag4-1) with splenocytes from mice immunized with human lymphoblastoid cells (RPMI-6410t line, acute myeloblastic leukemia). Hybridomas of the first type synthesize monoclonal antibodies Ma-1, which interact with 6410t-cells, but are not bound to the cells of human Burkitt lymphoma-Raji. Raji cells contain HLA-DRw5 and -DRw6 antigens on cell surface but there are no HLA-A2, -B7 and -B12 antigens (specific for 6410t). Thus, Ma-1 are probably derected against some of HLA antigens of loci A or B. Hybridomas of the second type synthesize Ma-2 antibodies which react with 6410t and Raji cells, but are not bound to peripheral blood lymphocytes (PBL). We suppose that Ma-2 antibodies to tumor specific antigens which have common antigen determinants both for Raji and RPMI-6410t cells. The third type of hybridomas synthesizes monoclonal antibodies Ma-3 reacting with all the three types of target cells: 6410t, Raji, and PBL. Ma-3 seems to be directed against human species-specific lymphocyte antigens which remained in 6410t and Raji cells.
AuthorsT M Seregina, M I Mekshenkov
JournalTsitologiia (Tsitologiia) Vol. 28 Issue 9 Pg. 976-80 (Sep 1986) ISSN: 0041-3771 [Print] Russia (Federation)
Vernacular TitleGibridomy, sinteziruiushchie monoklonal'nye antitela k poverkhnostnym antigenam limfotsitov cheloveka.
PMID3798564 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Surface
Topics
  • Animals
  • Antibodies, Monoclonal (analysis, biosynthesis)
  • Antibody Specificity
  • Antigens, Surface (analysis, immunology)
  • Cell Line
  • Humans
  • Hybridomas (immunology)
  • Lymphocytes (immunology)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: